Key facts
- This page summarizes Dennis Cho's Form 4 filing for Twist Bioscience Corp (TWST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jun 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026.
SEC remarks
Senior Vice President, Chief Legal Officer & Corporate Secretary